BTX · Categories · Form 4

BTX - SEC Form 4 insider transactions

BlackRock Technology and Private Equity Term Trust (BTX) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for BTX

• 127d
  SEC Form 4 filed by Portfolio Manager Menge Steven Reid

  4 - BlackRock Technology & Private Equity Term Trust (0001836057) (Issuer)
• 127d
  SEC Form 4 filed by Portfolio Manager Kim Tony

  4 - BlackRock Technology & Private Equity Term Trust (0001836057) (Issuer)
• 170d
  Director Fairbairn Robert W sold $143,027 worth of shares (21,937 units at $6.52), closing all direct ownership in the company (SEC Form 4)

  4 - BlackRock Technology & Private Equity Term Trust (0001836057) (Issuer)
• 335d
  Large owner Saba Capital Management, L.P. disposed of $454,458,709 worth of shares (60,675,395 units at $7.49) (SEC Form 4)

  4 - BlackRock Technology & Private Equity Term Trust (0001836057) (Issuer)
• 889d
  SEC Form 4 filed by Luther Sanjeev

  4 - Eterna Therapeutics Inc. (0000748592) (Issuer)
• 889d
  SEC Form 4 filed by Clarke Dorothy J

  4 - Eterna Therapeutics Inc. (0000748592) (Issuer)
• 903d
  SEC Form 4 filed by Cherington Charles

  4 - Eterna Therapeutics Inc. (0000748592) (Issuer)
• 905d
  SEC Form 4 filed by Freebird Partners Lp

  4 - Eterna Therapeutics Inc. (0000748592) (Issuer)
• 1020d
  SEC Form 4 filed by Cherington Charles

  4 - Eterna Therapeutics Inc. (0000748592) (Issuer)
• 1035d
  SEC Form 4 filed by Binder Brant

  4 - Eterna Therapeutics Inc. (0000748592) (Issuer)
• 1035d
  SEC Form 4 filed by Wagner Richard W

  4 - Eterna Therapeutics Inc. (0000748592) (Issuer)
• 1058d
  SEC Form 4 filed by Binder Brant

  4 - Eterna Therapeutics Inc. (0000748592) (Issuer)
• 1058d
  SEC Form 4 filed by Wagner Richard W

  4 - Eterna Therapeutics Inc. (0000748592) (Issuer)
• 1059d
  SEC Form 4 filed by Freebird Partners Lp

  4 - Eterna Therapeutics Inc. (0000748592) (Issuer)
• 1083d
  SEC Form 4 filed by Gurrola Sandra M

  4 - Eterna Therapeutics Inc. (0000748592) (Issuer)
• 1244d
  SEC Form 4 filed by Angel Matthew

  4 - Eterna Therapeutics Inc. (0000748592) (Issuer)
• 1282d
  SEC Form 4: Cherington Charles bought $858,560 worth of shares (261,756 units at $3.28), increasing direct ownership by 89% to 556,465 units

  4 - Eterna Therapeutics Inc. (0000748592) (Issuer)
• 1282d
  SEC Form 4: Singer Nicholas Jason bought $929,178 worth of shares (283,286 units at $3.28)

  4 - Eterna Therapeutics Inc. (0000748592) (Issuer)
• 1283d
  SEC Form 4: Halpern John D bought $1,101,818 worth of shares (335,920 units at $3.28)

  4 - Eterna Therapeutics Inc. (0000748592) (Issuer)
• 1358d
  SEC Form 4: Sidhu Roger converted options into 20,163 shares

  4 - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Issuer)
• 1407d
  SEC Form 4 filed by Cherington Charles

  4 - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Issuer)
• 1407d
  SEC Form 4 filed by Angel Matthew

  4 - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Issuer)
• 1407d
  SEC Form 4 filed by Singer Nicholas Jason

  4 - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Issuer)
• 1407d
  SEC Form 4 filed by Fiore Gregory

  4 - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Issuer)
• 1407d
  SEC Form 4 filed by Wexler William A.

  4 - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Issuer)
• 1442d
  SEC Form 4: Damour Kevin converted options into 17,573 shares and covered exercise/tax liability with 6,077 shares

  4 - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Issuer)
• 1448d
  SEC Form 4: Gurrola Sandra M converted options into 8,750 shares and covered exercise/tax liability with 3,586 shares, increasing direct ownership by 63% to 13,367 units

  4 - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Issuer)
• 1465d
  SEC Form 4 filed by Jackson Andrew C.

  4 - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Issuer)
• 1546d
  SEC Form 4 filed by Gurrola Sandra M (Amendment)

  4/A - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Issuer)
• 1546d
  SEC Form 4 filed by Damour Kevin (Amendment)

  4/A - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Issuer)
• 1546d
  SEC Form 4 filed by Sidhu Roger (Amendment)

  4/A - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Issuer)
• 1546d
  SEC Form 4 filed by Sial Jay (Amendment)

  4/A - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Issuer)
• 1546d
  SEC Form 4 filed by Federoff Howard J. (Amendment)

  4/A - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Issuer)
• 1548d
  SEC Form 4 filed by Gurrola Sandra M

  4 - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Issuer)
• 1548d
  SEC Form 4 filed by Damour Kevin

  4 - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Issuer)
• 1548d
  SEC Form 4 filed by Federoff Howard J.

  4 - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Issuer)
• 1548d
  SEC Form 4 filed by Sidhu Roger

  4 - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Issuer)
• 1548d
  SEC Form 4 filed by Sial Jay

  4 - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Issuer)
• 1603d
  SEC Form 4 filed by Enright Erin S.

  4 - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Issuer)
• 1603d
  SEC Form 4 filed by Redman Heather B

  4 - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Issuer)
• 1643d
  SEC Form 4 filed by Mohr Erich

  4 - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Issuer)
• 1643d
  SEC Form 4: Cherington Charles acquired 92 shares, increasing direct ownership by 0.00% to 5,894,193 units

  4 - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Issuer)
• 1643d
  SEC Form 4 filed by Greenwood Luba

  4 - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Issuer)
• 1643d
  SEC Form 4 filed by Langer Dennis

  4 - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Issuer)
• 1722d
  SEC Form 4 filed by Sidhu Roger

  4 - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Issuer)
• 1755d
  SEC Form 4: DENNY GEORGE P III bought $40 worth of Common Stock (3 units at $13.48) and sold $1,204,688 worth of Common Stock (75,000 units at $16.06)

  4 - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Issuer)
• 1787d
  SEC Form 4 filed by Sial Jay

  4 - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Issuer)
• 1806d
  SEC Form 4 filed by DAmour Kevin

  4 - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Issuer)
• 1814d
  SEC Form 4 filed by Gurrola Sandra M

  4 - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Issuer)
• 1815d
  SEC Form 4: Cherington Charles sold $6,296,568 worth of Common Stock (400,000 units at $15.74), decreasing direct ownership by 6% to 5,894,101 units

  4 - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Issuer)
• 1877d
  SEC Form 4 filed by Federoff Howard J.

  4 - Brooklyn ImmunoTherapeutics, Inc. (0000748592) (Issuer)

Other BTX categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends